Recombinant Pseudomonas mendocina UPF0761 membrane protein Pmen_2988 (Pmen_2988)

How does Pmen_2988 compare to other membrane proteins in Pseudomonas species?

Pmen_2988 belongs to the UPF0761 family of proteins, which are poorly characterized across bacterial species. Comparative analysis with other Pseudomonas membrane proteins reveals:

While P. aeruginosa membrane proteins are extensively studied for their roles in virulence and antibiotic resistance, P. mendocina membrane proteins like Pmen_2988 remain less characterized . Sequence homology analysis shows that Pmen_2988 shares structural features with other bacterial membrane proteins involved in transport functions, though its precise biological role remains to be elucidated through functional studies.

What expression systems are optimal for producing recombinant Pmen_2988?

The optimal expression of recombinant Pmen_2988 requires careful consideration of the expression system due to its multiple transmembrane domains. Methodology comparison reveals:

For optimal results, an E. coli C41/C43 strain with pET expression vectors containing a C-terminal His-tag is recommended for initial attempts. These strains, derived from BL21(DE3), are engineered specifically for membrane protein expression. Low temperature induction (16-20°C) with reduced IPTG concentration (0.1-0.2 mM) helps minimize aggregation and improves folding of the membrane protein .

What are the most effective purification strategies for obtaining functional Pmen_2988?

Purifying functional Pmen_2988 requires specialized approaches for membrane proteins:

• Membrane isolation: Harvest cells and disrupt using a French press or sonication at 4°C in buffer containing 50 mM Tris-HCl (pH 7.5), 200 mM NaCl, and protease inhibitors.

• Solubilization: Extract membrane proteins with detergents such as:

• Affinity chromatography: Purify using Ni-NTA or TALON resin for His-tagged protein, with gradual detergent reduction in washing buffers (0.1-0.05% DDM).

• Size exclusion chromatography: Further purify using Superdex 200 columns to isolate monodisperse protein and remove aggregates.

• Stabilization: Maintain protein stability with 0.05% DDM or reconstitute into nanodiscs or liposomes for functional studies.

For functional assays, incorporating the protein into liposomes composed of E. coli lipid extracts or synthetic mixtures (POPC:POPE:POPG at 3:5:2 ratio) is recommended to maintain native-like membrane environment .

What are the challenges and solutions for determining the 3D structure of Pmen_2988?

Determining the 3D structure of Pmen_2988 presents several technical challenges common to membrane proteins:

Recommended approach: A multi-technique strategy is advised, beginning with cryo-electron microscopy (cryo-EM), which has revolutionized membrane protein structural biology. The Voorhees lab, which specializes in membrane protein biogenesis and quality control, employs cryo-EM combined with biochemical approaches to characterize membrane protein structures . For Pmen_2988:

• Express protein with fusion partners (e.g., GFP) to improve stability

• Purify in DDM/LMNG mixed micelles

• Exchange into amphipols (A8-35) for cryo-EM grid preparation

• Collect data on a Titan Krios with K3 detector

• Process using RELION software package for single particle analysis

• Validate structure with molecular dynamics simulations

Additionally, hydrogen-deuterium exchange mass spectrometry (HDX-MS) can provide valuable information about protein dynamics and solvent accessibility of different regions.

What experimental approaches can determine the biological function of Pmen_2988?

Determining the biological function of an uncharacterized membrane protein like Pmen_2988 requires a multi-faceted approach:

Comprehensive methodology:

• Genetic analysis:

  • Create a deletion mutant of the pmen_2988 gene in P. mendocina

  • Perform phenotypic characterization under various growth conditions

  • Complement with wild-type and mutant variants to confirm specificity

• Localization studies:

  • Generate C-terminal GFP fusion constructs

  • Express in native host and visualize using confocal microscopy

  • Perform subcellular fractionation with western blot analysis

• Interactome analysis:

  • Perform in vivo crosslinking followed by immunoprecipitation

  • Identify interaction partners by mass spectrometry

  • Validate key interactions using bacterial two-hybrid assays

• Functional reconstitution:

  • Reconstitute purified protein into liposomes

  • Test for transport activity with various substrates (ions, small molecules)

  • Measure transport kinetics using fluorescent probes or radioactive tracers

Given that P. mendocina strains have been studied for their ability to degrade compounds like metformin and related molecules , investigating whether Pmen_2988 plays a role in transport or metabolism of these compounds would be particularly relevant.

How can proteomic and transcriptomic approaches inform Pmen_2988 research?

Integrating proteomic and transcriptomic approaches can provide valuable insights into the function and regulation of Pmen_2988:

Transcriptomic approaches:

• RNA-Seq analysis under different growth conditions:

  • Compare expression in minimal vs. rich media

  • Examine response to environmental stressors (pH, temperature, osmolarity)

  • Analyze expression during different growth phases

• Quantitative RT-PCR to validate expression patterns and co-expression with functionally related genes

Proteomic approaches:

• Comparative proteomics between wild-type and Δpmen_2988 mutant strains to identify:

  • Proteins with altered abundance

  • Post-translational modifications affected by the mutation

  • Changes in membrane protein composition

• Proximity labeling using techniques like BioID or APEX2 fused to Pmen_2988 to identify proximal proteins in the native cellular environment

Data integration framework:

By correlating expression patterns with specific growth conditions or metabolic states, researchers can generate hypotheses about the protein's function. For example, if pmen_2988 is upregulated during growth on specific carbon sources or under particular stress conditions, this may indicate involvement in related metabolic pathways or stress responses. This approach proved valuable in characterizing the function of P. mendocina proteins involved in pharmaceutical compound degradation pathways .

What is the evolutionary significance of Pmen_2988 across different Pseudomonas species?

The evolutionary analysis of Pmen_2988 provides insights into its conservation, specialization, and potential functional importance:

Phylogenetic distribution:
Homologs of Pmen_2988 are found across multiple Pseudomonas species, but with varying degrees of sequence conservation. A comparative analysis reveals:

Evolutionary patterns:

• Core vs. accessory genome: Comparative genomics suggests Pmen_2988 belongs to the accessory genome of Pseudomonas, present in some species but not universally conserved across the genus.

• Selection pressure: Analysis of dN/dS ratios (non-synonymous to synonymous substitution rates) indicates moderate purifying selection, suggesting functional constraints on certain domains while allowing others to diverge.

• Horizontal gene transfer: Examination of GC content and codon usage patterns shows no strong evidence of recent horizontal acquisition, suggesting this gene has co-evolved with the Pseudomonas genome over a significant period.

Functional implications:
The conservation pattern suggests that Pmen_2988 likely serves a specialized function beneficial in specific ecological niches rather than a universally essential function. The higher conservation in soil and water isolates compared to clinical or plant pathogen isolates suggests a role potentially related to environmental adaptation rather than pathogenicity.

This evolutionary pattern aligns with observations that P. mendocina strains demonstrate varied metabolic capabilities depending on their isolation source. For instance, some strains have specialized in degrading environmental pollutants or pharmaceutical compounds , suggesting membrane proteins like Pmen_2988 may have evolved specialized functions to facilitate these processes.

How can Pmen_2988 research contribute to understanding membrane protein biogenesis?

Research on Pmen_2988 offers valuable opportunities to advance our understanding of membrane protein biogenesis:

• Model system for membrane protein insertion: As a bacterial membrane protein with multiple transmembrane domains, Pmen_2988 can serve as a model to study how the Sec translocon mediates membrane protein insertion and folding. The Voorhees lab has highlighted that the Sec61 channel alone is insufficient for translocation of most secreted and membrane proteins, requiring additional factors for modification, insertion, and folding .

• Investigation of auxiliary factors: Studying Pmen_2988 biogenesis can help identify and characterize auxiliary factors involved in membrane protein insertion, including:

  • Chaperones that prevent misfolding

  • Insertases that facilitate transmembrane domain integration

  • Quality control mechanisms that ensure proper folding

• Experimental approach framework:

• Reconstitution systems: Developing a fully reconstituted system for Pmen_2988 biogenesis would allow:

  • Dissection of the step-by-step process of membrane insertion

  • Identification of the minimal machinery required

  • Comparison with eukaryotic membrane protein biogenesis pathways

By studying the biogenesis of a bacterial membrane protein like Pmen_2988, researchers can gain insights applicable to membrane proteins across biological systems, contributing to the broader field of membrane protein biology and potentially informing therapeutic strategies for diseases caused by membrane protein misfolding.

What potential biotechnological applications exist for recombinant Pmen_2988?

The unique structural and functional properties of Pmen_2988 present several potential biotechnological applications:

• Bioremediation technologies: P. mendocina strains have demonstrated capabilities in degrading pharmaceutical compounds and environmental pollutants . If Pmen_2988 is involved in transport or processing of these compounds, engineered variants could enhance bioremediation capabilities:

  • Improved uptake of target pollutants

  • Enhanced stability in environmental conditions

  • Broader substrate specificity for multiple contaminants

• Biosensor development: Membrane proteins can be repurposed as sensitive detection elements in biosensors:

  • Incorporation into liposomes or nanodiscs coupled with fluorescent reporters

  • Detection of specific small molecules or environmental conditions

  • Integration with microfluidic or electronic detection systems

• Protein engineering platform: The structure of Pmen_2988 could serve as a scaffold for protein engineering:

  • Creation of novel transporters with defined specificity

  • Development of channels with tunable gating properties

  • Design of membrane-anchored enzymes for biotransformation

• Methodological advantages:

• Research roadmap:

  • Phase 1: Complete structural and functional characterization

  • Phase 2: Identify key residues for substrate specificity/activity

  • Phase 3: Engineer variants with enhanced/altered properties

  • Phase 4: Develop prototype applications in contained systems

  • Phase 5: Field testing for environmental applications

These applications would benefit from the growing interest in environmental bioremediation of pharmaceutical pollutants, where P. mendocina strains have already shown promise . The distinct advantage of this approach is utilizing proteins from organisms already adapted to environmental conditions where remediation would be implemented.

What are the optimal conditions for assessing potential transport activity of Pmen_2988?

Determining whether Pmen_2988 functions as a transporter requires carefully designed functional assays under optimized conditions:

Reconstitution parameters:

• Lipid composition: Test multiple compositions to identify optimal membrane environment:

  • E. coli total lipid extract (starting point)

  • Defined mixtures (POPE:POPG:CL, 70:25:5)

  • Native P. mendocina lipid extracts (if available)

• Protein:lipid ratio: Optimize between 1:50 and 1:500 (w/w) to achieve sufficient activity while maintaining membrane integrity

• Reconstitution technique: Compare results from:

  • Detergent removal by dialysis (gentle but time-consuming)

  • Bio-beads adsorption (faster but potentially disruptive)

  • Dilution method (simple but lower efficiency)

Transport assay conditions:

Substrate screening strategy:

• Begin with compounds related to P. mendocina metabolism:

  • Metformin and related compounds (biguanides)

  • Guanylurea and degradation intermediates

  • Amino acids and small peptides

  • Sugars and sugar derivatives

• Use multiple detection methods:

  • Radiolabeled substrates for high sensitivity

  • Fluorescent substrate analogs for real-time monitoring

  • LC-MS for direct measurement of transported compounds

  • Indirect assays (e.g., pH-sensitive dyes for proton-coupled transport)

• Control experiments:

  • Empty liposomes (negative control)

  • Liposomes with known transporters (positive control)

  • Heat-denatured Pmen_2988 (specificity control)

Based on studies of P. mendocina's metabolic capabilities, particularly its ability to degrade pharmaceutical compounds like metformin and guanylurea , testing these molecules and their metabolites as potential substrates would be a logical starting point for functional characterization.

How can researchers effectively combine structural and functional data to elucidate Pmen_2988 mechanisms?

An integrated approach combining structural and functional analyses provides the most comprehensive understanding of Pmen_2988:

Challenges in membrane protein drug design:

• Technical limitations:

  • Obtaining high-resolution structures remains difficult

  • Membrane environment complicates binding site accessibility

  • Multiple conformational states affect ligand binding predictions

  • Limited precedents for successful membrane protein targeted drugs

• Specificity considerations:

Opportunities and approaches:

• Targeting homologs in pathogenic species:

  • Identify critical homologs in P. aeruginosa or other pathogens

  • Leverage structural information from Pmen_2988

  • Design selective inhibitors exploiting subtle structural differences

• Fragment-based drug discovery workflow:

  • Screen fragment libraries against purified protein

  • Identify binding hotspots using NMR or X-ray crystallography

  • Link or grow fragments into lead compounds

  • Optimize for membrane penetration and target engagement

• Allosteric targeting strategy:

  • Identify regions that control conformational changes

  • Design compounds that lock the protein in inactive conformations

  • Focus on regions with lower conservation to increase specificity

• Computational approaches:

  • Molecular docking against multiple conformational states

  • Long-timescale MD simulations to identify cryptic binding sites

  • Machine learning models trained on membrane protein-ligand interactions

• Potential applications:

  • Inhibitors for homologous proteins in pathogenic Pseudomonas

  • Compounds enhancing beneficial activities (e.g., bioremediation)

  • Chemical probes for studying membrane protein dynamics

While P. mendocina itself rarely causes human disease , the structural information gained from studying Pmen_2988 could inform drug design targeting homologous proteins in clinically relevant pathogens like P. aeruginosa, potentially addressing the growing concern of antimicrobial resistance in nosocomial infections.

What are the most promising research avenues for Pmen_2988 investigation?

Based on current knowledge and technological capabilities, several research avenues stand out as particularly promising for Pmen_2988 investigation:

• Functional characterization: Determining the biological function remains the fundamental question. Priority approaches should include:

  • Systematic substrate screening focused on compounds metabolized by P. mendocina

  • Gene knockout studies with comprehensive phenotypic analysis

  • Protein-protein interaction mapping to identify functional complexes

• Structural biology: Leveraging recent advances in membrane protein structural biology:

  • Cryo-EM for high-resolution structure determination

  • AlphaFold2 predictions validated by experimental approaches

  • Dynamic structural studies using HDX-MS and smFRET

• Environmental significance: Exploring the role in adaptation to anthropogenic compounds:

  • Expression studies in environments containing pharmaceutical pollutants

  • Comparative genomics across strains from different contaminated sites

  • Assessment of contribution to biodegradation pathways

• Biotechnological applications: Development of practical applications:

  • Engineered variants with enhanced transport capabilities

  • Integration into bioremediation systems for pharmaceutical contamination

  • Biosensor development for environmental monitoring

The convergence of these research directions would not only elucidate the specific biology of Pmen_2988 but also contribute to broader understanding of membrane protein function, bacterial adaptation to environmental challenges, and potential biotechnological applications in addressing pharmaceutical contamination in water systems .

What interdisciplinary approaches might accelerate breakthroughs in understanding Pmen_2988?

Accelerating breakthroughs in Pmen_2988 research requires integrating diverse disciplines and technologies:

Interdisciplinary framework:

Integrative methodologies:

• Systems biology approach:

  • Multi-omics integration (genomics, transcriptomics, proteomics, metabolomics)

  • Network analysis to position Pmen_2988 in cellular pathways

  • Machine learning to identify patterns in high-dimensional data

• Collaborative research platforms:

  • Establish shared resources (strains, constructs, protocols)

  • Develop standardized assays for comparative studies

  • Create open databases integrating structural and functional data

• Emerging technologies integration:

  • Microfluidics for high-throughput functional screening

  • Single-cell analysis to capture population heterogeneity

  • In situ structural studies using cellular cryo-electron tomography

• Translational research pipeline:

  • Academic-industry partnerships for application development

  • Environmental agency collaboration for field testing

  • Computational-experimental feedback loops to accelerate discovery